@ghazeskandari.bsky.social
77 followers 72 following 19 posts
Microglia and protein misfolding enthusiast. Postdoctoral fellow @Burton-Johes lab @UCI MIND 🇺🇸, LLHF and Brightfocus Fellow UAlberta alumni 🇨🇦, studying microglia and human iMG in health and disease 🧠🧫🔬 🧬🧪
Posts Media Videos Starter Packs
Pinned
ghazeskandari.bsky.social
This amazing news made my week! 🎊 I’m beyond blessed to be part of the @brightfocus.bsky.social community while studying the protective microglial responses in the context of Alzheimer’s disease. Super thankful to @blurtonjoneslab.bsky.social and the entire MBJ team for their continuous support!
Reposted
johnsonlab.bsky.social
new preprint from @iostephens.bsky.social describes the potential benefits of increasing lipid turnover in microglia by eliminating PLIN2 from their surface
biorxiv-neursci.bsky.social
Knockout of Perilipin 2 in Microglia Alters Lipid Droplet Accumulation and Response to Alzheimer's Disease Stimuli https://www.biorxiv.org/content/10.1101/2025.09.02.673815v1
ghazeskandari.bsky.social
Thanks for putting together such a fantastic meeting, and for the opportunity to present! It was great to be part of the conversation with the rest of speakers.
ismnd.bsky.social
👏 Great start to NextGen 2025!
S1: Cellular Immune Responses in the Pathogenesis of #AlzheimersDisease

Hosts: Kristine Freude & Marion Kadlecová

Speakers
🔹 Ghazaleh Eskandari-Sedighi
🔹 Lukas Busch
🔹 Johannes Schlachetzki
🔹 Zhiyuan Ning
🔹 Guoyan Zhao
Reposted
ismnd.bsky.social
👏 Great start to NextGen 2025!
S1: Cellular Immune Responses in the Pathogenesis of #AlzheimersDisease

Hosts: Kristine Freude & Marion Kadlecová

Speakers
🔹 Ghazaleh Eskandari-Sedighi
🔹 Lukas Busch
🔹 Johannes Schlachetzki
🔹 Zhiyuan Ning
🔹 Guoyan Zhao
Reposted
johnsonlab.bsky.social
Are you an ATP!?!

We are hosting our 2nd annual CNS MET Symposium 12/3/25 and are searching for early-career researchers to highlight as All-star Trainee Presentations (ATPs).

Up to 4 individuals will be invited for an all-expense paid trip to beautiful Lexington KY.

Apply here! rb.gy/3zk4cm
Reposted
canacn.bsky.social
Identification of CD33m as a new protective factor in Alzheimer’s Disease development. Read about this research by Brain Star Award winner Ghazaleh Eskandari-Sedighi can-acn.org/brain-star-a... @ualberta.bsky.social @ghazeskandari.bsky.social
Reposted
glyconet.bsky.social
Join us for the next GTA webinar on Siglecs and their glycan ligands, featuring Dr. @siglecdude.bsky.social (U of A) and Dr. Edward Schmidt. Learn how their team is developing novel tools to uncover the biological roles of Siglecs across systems.

Register: canadianglycomics.ca/training/web...
ghazeskandari.bsky.social
Woohoo! Congrats to both of you guys! 🍾🎊
Reposted
sarahnaguib.bsky.social
So proud to share my first first-author paper from my postdoc in @liganlab.bsky.social out yesterday in
@cp-immunity.bsky.social! We characterized a model of the APOE3 Christchurch mutation on a tauopathy background and found downregulation of cGAS-STING-IFN pathway as a source of protection!
liganlab.bsky.social
🚨Our new paper is out!🚨 We uncover a protective mechanism of the rare APOE3 Christchurch (R136S) mutation against tauopathy—by suppressing microglial cGAS–STING–interferon (IFN) pathway, a key inflammatory axis triggered by tau. www.sciencedirect.com/science/arti...
The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway
The Christchurch mutation (R136S) in the APOE3 (E3S/S) gene is associated with attenuated tau load and cognitive decline despite the presence of a cau…
www.sciencedirect.com
Reposted
maximoprado.bsky.social
For #fluorescencefriday the Mesoscopic Integrated NeuroImaging Data (MIND) platform @westernu.bsky.social presents abeta plaques and blood vessels in the 🧠 of our ApoE4 mouse model of AD. 🧪 #clearing #lightsheet 🔬 Courtesy of Arash Salahinejad, Luke Smolders and @shahrzadbahrampour.bsky.social
ghazeskandari.bsky.social
The registration for the second round of 2025 Canadian Neuroscience Series are open now. This was a fantastic opportunity for me to learn about the impressive work of other #postdocs and share mine with them. Highly recommend it to anyone eligible in the field of #Neuroscience.
cns-pds.bsky.social
🇨🇦 🧠 Are you a #Postdoc in #Canada or #Canadian abroad? We are selecting #speakers for the (second round of the) 2025 Canadian #Neuroscience #Seminars: Postdoctoral Series. Apply by July 6th, 2025 @ 23:59PT.

Find more details here: tinyurl.com/56m946jh

Apply through this form: tinyurl.com/42cwhae3
Reposted
cns-pds.bsky.social
🇨🇦 🧠 Are you a #Postdoc in #Canada or #Canadian abroad? We are selecting #speakers for the (second round of the) 2025 Canadian #Neuroscience #Seminars: Postdoctoral Series. Apply by July 6th, 2025 @ 23:59PT.

Find more details here: tinyurl.com/56m946jh

Apply through this form: tinyurl.com/42cwhae3
Reposted
ghazeskandari.bsky.social
Thanks to @canacn.bsky.social and #CIHR for choosing my work on human CD33 isoforms in Alzheimer’s disease for a #brainstar_award. I share the credit with Matt Macauley lab @siglecdude.bsky.social and all the amazing co-authors whose tremendous help was a huge contribution to this project.
canacn.bsky.social
Very proud to announce the winners of the 2024 Brain Star Awards! can-acn.org/congratulati...
Très fiers d'annoncer les gagnants des prix Cerveau en tête 2024! can-acn.org/fr/bravo-aux...
Reposted
canacn.bsky.social
Very proud to announce the winners of the 2024 Brain Star Awards! can-acn.org/congratulati...
Très fiers d'annoncer les gagnants des prix Cerveau en tête 2024! can-acn.org/fr/bravo-aux...
ghazeskandari.bsky.social
Thanks, Matt! Appreciate your kind words and support.
Reposted
cns-pds.bsky.social
Meet our first speaker 🗣️ Ghazaleh will be presenting at our webinar THIS Thursday! You can register here: zoom.us/webinar/regi...

And remember, you can stay up to date on webinars, events, and more by subscribing to our mailing list: t.co/Oa9dLowy1h
Reposted
cns-pds.bsky.social
Happening THIS week!

Register here: zoom.us/webinar/regi...

Stay up to date by subscribing to our mailing list: t.co/Oa9dLowy1h